ORIC R&D Expense Growth
Oric Pharmaceuticals Inc · R&D Expense Growth
ORIC R&D Expense Growth
Latest reported15.46%period ending
ORIC Quarterly R&D Growth (QoQ) (0.00% → 15.46%)
Latest values, visible window
High-resolution chart · PNG
ORIC r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 15.4563% | |
| 21.5849% | |
| -10.138% | |
| -5.8136% | |
| 23.9813% | |
| -22.9277% | |
| 2.4614% | |
| 7.8162% | |
| 31.7851% | |
| -10.2978% | |
| 9.3488% | |
| 19.1675% | |
| -3.7354% | |
| 19.7668% | |
| 10.6772% | |
| 6.4262% | |
| -17.7918% | |
| 0.4957% | |
| 29.8163% | |
| -16.8718% | |
| 32.6579% | |
| -3.4343% | |
| 37.1645% | |
| 14.3468% | |
| 6.4654% | |
| 4.2241% | |
| 23.5795% | |
| 11.746% | |
| -3.3001% | |
| 0% |